{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:51Z","timestamp":1786119471329,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/iae.0b013e3181b9f153","type":"journal-article","created":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T01:44:03Z","timestamp":1265075043000},"page":"281-286","source":"Crossref","is-referenced-by-count":45,"title":["AQUEOUS VASCULAR ENDOTHELIAL GROWTH FACTOR LEVELS ARE ASSOCIATED WITH SEROUS MACULAR DETACHMENT SECONDARY TO BRANCH RETINAL VEIN OCCLUSION"],"prefix":"10.1097","volume":"30","author":[{"given":"SUNG PYO","family":"PARK","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAE KYOUN","family":"AHN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GUI HYEONG","family":"MUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210130","first-page":"178","article-title":"The natural course of temporal retinal vein occlusion.","volume":"78","author":"Gutman","year":"1997","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"R2-12-20210130","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3928\/1542-8877-20010701-03","article-title":"Structural changes of the retina in retinal vein occlusion-Imaging and quantification with optical coherence tomography.","volume":"32","author":"Lerche","year":"2001","journal-title":"Ophthalmic Surg Lasers"},{"key":"R3-12-20210130","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/01.iae.0000254893.94013.16","article-title":"Serous macular detachment in branch retinal vein occlusion.","volume":"26","author":"Yamaguchi","year":"2006","journal-title":"Retina"},{"key":"R4-12-20210130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00006982-200306000-00009","article-title":"Optical coherence tomography of branch retinal vein occlusion.","volume":"23","author":"Spaide","year":"2003","journal-title":"Retina"},{"key":"R5-12-20210130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10792-007-9123-0","article-title":"Natural history of macular status in recent-onset branch retinal vein occlusion: an optical coherence tomography study.","volume":"28","author":"Shroff","year":"2008","journal-title":"Int Ophthalmol"},{"key":"R6-12-20210130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000267567","article-title":"Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels.","volume":"27","author":"Murata","year":"1995","journal-title":"Ophthalmic Res"},{"key":"R7-12-20210130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0161-6420(98)93020-2","article-title":"Vascular endothelial growth factor upregulation in human central retinal vein occlusion.","volume":"105","author":"Pe'er","year":"1998","journal-title":"Ophthalmology"},{"key":"R8-12-20210130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1442-9071.2009.01909.x","article-title":"Changes of aqueous vascular endothelial growth factor and interleukin-6 after intravitreal triamcinolone for branch retinal vein occlusion.","volume":"36","author":"Park","year":"2008","journal-title":"Clin Exp Ophthalmol"},{"key":"R9-12-20210130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00417-004-1087-4","article-title":"Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion.","volume":"244","author":"Noma","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R10-12-20210130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ajo.2005.03.003","article-title":"Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6.","volume":"140","author":"Noma","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R11-12-20210130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.preteyeres.2004.05.002","article-title":"Neuroprotective and anti-angiogenic actions of PEDF in the eye: molecular targets and therapeutic potential.","volume":"23","author":"Barnstable","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"R12-12-20210130","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00125-003-1040-9","article-title":"Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy.","volume":"46","author":"Boehm","year":"2003","journal-title":"Diabetologia"},{"key":"R13-12-20210130","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.exer.2005.10.002","article-title":"Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: implications for structural differences in macular profiles.","volume":"82","author":"Patel","year":"2006","journal-title":"Exp Eye Res"},{"key":"R14-12-20210130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.eye.6702498","article-title":"Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion.","volume":"22","author":"Noma","year":"2008","journal-title":"Eye"},{"key":"R15-12-20210130","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/00006982-200410000-00012","article-title":"Serous macular detachment secondary to distant retinal vascular disorders.","volume":"24","author":"Otani","year":"2004","journal-title":"Retina"},{"key":"R16-12-20210130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcp.1114","article-title":"Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.","volume":"188","author":"Mori","year":"2001","journal-title":"J Cell Physiol"},{"key":"R17-12-20210130","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1167\/iovs.08-2332","article-title":"Retinal gene expression and Muller cell responses after branch retinal vein occlusion in the rat.","volume":"50","author":"Rehak","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-12-20210130","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0006-291X(03)00446-7","article-title":"Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells.","volume":"303","author":"Ohno-Matsui","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R19-12-20210130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ajo.2006.12.037","article-title":"Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion.","volume":"143","author":"Pai","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R20-12-20210130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IAE.0b013e318030e77e","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion.","volume":"27","author":"Rabena","year":"2007","journal-title":"Retina"},{"key":"R21-12-20210130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/bjo.2007.123513","article-title":"Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion.","volume":"92","author":"Kreutzer","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R22-12-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00417-008-0916-2","article-title":"One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion.","volume":"247","author":"Jaissle","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0b013e3181b9f153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:19:03Z","timestamp":1786040343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201002000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181b9f153","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}